Prothena Corp Public (PRTA) Net Margin Growth (1y) (2013 - 2026)

Prothena Corp Public (PRTA) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -763.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 447.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 673.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,097.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,208.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,636.00
10 Prothena Corp Public 458.45 Mn 170.25 Mn - 100,551.00

Historic Data

Download Data
DateValue
Jun 30, 2026 100,551.00
Mar 31, 2026 219,259.00
Dec 31, 2025 -9.98 Mn
Sep 30, 2025 457,430.00
Jun 30, 2025 -289,604.00
Mar 31, 2025 14.23 Mn
Dec 31, 2024 1.86 Mn
Sep 30, 2024 -611,201.00
Jun 30, 2024 140,921.00
Mar 31, 2024 -14.23 Mn
Dec 31, 2023 -2.14 Mn
Sep 30, 2023 303,947.00
Jun 30, 2023 178,716.00
Mar 31, 2023 98,626.00
Dec 31, 2022 284,053.00
Sep 30, 2022 -309,214.00
Jun 30, 2022 -319,167.00
Mar 31, 2022 1.98 Mn
Dec 31, 2021 570,441.00
Sep 30, 2021 1.96 Mn